CALCiViS was co-founded in 2012 by Adam Christie (CEO) and Bruce Vernon (CTO). From its headquarters in Edinburgh, the CALCiViS team combines product development, clinical and commercial expertise. The CALCiViS imaging system was developed with input from leading International specialists in caries and erosion.
Since then multiple preclinical and clinical studies have been undertaken including one pivotal clinical study designed to support our regulatory filing to FDA.
The CALCiViS imaging system is a CE marked class IIa medical device in the UK and Europe.
CALCiViS is internationally focused and actively forming relationships with leading clinicians and other stakeholders in dental markets around the world.